Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02635282 · ClinicalTrials.gov registry record · Phase 4
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
A Phase 4 study, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT02635282: Completed Phase 4 study, sponsored by University of Tennessee.
NCT02635282 is a Phase 4 study that has completed, run by University of Tennessee. The registered enrollment target is 19 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02635282, a Phase 4 study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.
Primary Outcome
The Faces Pain Scale-Revised will be used for children ages 3-7 years
Interventions
- DRUG intranasal ketamine
- DRUG intranasal fentanyl
- DRUG intranasal midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-03-23 |
| Phase | Phase 4 |
What the finished NCT02635282 record still lists
NCT02635282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which intranasal ketamine is the first listed.
NCT02635282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02635282 about?
NCT02635282 is a clinical study titled "IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D". The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.
What is the current status of trial NCT02635282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2016-08. Estimated completion is 2017-03-23.
What interventions are being tested in trial NCT02635282?
The interventions under investigation include: intranasal ketamine (DRUG), intranasal fentanyl (DRUG), intranasal midazolam (DRUG).
Who is sponsoring clinical trial NCT02635282?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02635282's enrollment target sits among peer trials
19 1834th of 2000 higher than 159 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia